la,25-Dihydroxyvitamin D3 [1,25(OH)2D3], the active metabolite of the steroid hormone vitamin D, is a potent regulator of macrophage and osteoclast differentiation. The mature osteoclast, unlike the circulating monocyte or the tissue macrophage, expresses high levels of carbonic anhydrase H (CAH). This enzyme generates protons and bicarbonate from water and carbon dioxide and is involved in bone resorption and acid-base regulation. To test whether 1,25(OH)2D3 could induce the differentiation of myelomonocytic precursors toward osteoclasts rather than macrophages, we analyzed its effects on the expression of CAll in bone marrow cultures containing precursors common to both cell types. The expression of CAU was markedly increased by 1,25(OH)2D3 in a doseand time-dependent manner. In bone marrow, this increase occurred at the mRNA and protein levels and was detectable as early as 24 hr after stimulation. 1,25(OH)2D3 was also found to induce CAH expression in a transformed myelomonocytic avian cell line. These results suggest that 1,25(OH)2D3 regulates the level at which myelomonocytic precursors express CAU, an enzyme that is involved in the function of the mature osteoclast. la,25-Dihydroxyvitamin D3 [1,25(OH)2D3] is the active metabolite of the steroid hormone vitamin D (1). This metabolite regulates the differentiation of osteoclasts and macrophages, two cell types that are thought to be derived from a common myelomonocytic precursor (2-6). 1,25(OH)2D3 induces an increase in bone resorption in vivo (1, 7) and in organ cultures (8, 9) but has no effect on the resorptive activity of isolated osteoclasts (10, 11). The increase in bone resorption is believed to be mediated primarily by means of an effect upon the proliferation and/or differentiation of osteoclast precursors within the hematopoietic bone marrow (12-15), leading to an increase in the number of mature osteoclasts (7,9 (13,14,19,20) and increases the proportion ofthe cells that can resorb bone (14).Taken together, these results suggest that this steroid hormone may specifically induce the differentiation of myelomonocytic precursors toward the macrophage and/or osteoclast lineage.One of the genes that is expressed at high levels in the osteoclast (21-23), but not in peripheral monocytes or mature macrophages (24), is the gene encoding carbonic anhydrase II (CAII). CAII is an enzyme that reversibly generates bicarbonate and protons from carbon dioxide and water (25). This enzyme plays an essential role in acid-secreting cells such as the kidney tubule intercalated cell (26), the gastric mucosa oxyntic cell (27), and the osteoclast (21). In humans, defective CAII is associated with cerebral calcification, tubular acidosis, and osteopetrosis (28), providing genetic evidence for CAII involvement in bone resorption. An analogue of the human disease has been produced by chemical mutagenesis in the mouse, where CAII deficiency is associated with renal tubular acidosis and vascular calcification but no major bone defects (29).We have investigated wheth...